United States: Recent FDA Initiatives To Support Development Of Individualized Cell And Gene Therapies And Rare Disease Therapies - Goodwin Procter LLP

United States: Recent FDA Initiatives To Support Development Of Individualized Cell And Gene Therapies And Rare Disease Therapies - Goodwin Procter LLP

Mondaq

Published

Last month, FDA issued a Request for Information (RFI) in the Federal Register seeking information and comments from interested stakeholders regarding...

Full Article